Summary & Overview
CPT 86977: Serum Incubation with Inhibitor for Antibody Identification
CPT code 86977 covers a specialized immunohematology laboratory procedure in which serum is incubated with an inhibitor to prepare the sample for identification of antibodies to red blood cells. This technique is important for accurate antibody detection in transfusion medicine and can affect blood compatibility testing and transfusion safety nationwide. Major national payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical purpose of 86977, the typical laboratory setting where it is performed, and how it fits into immunohematology workflows. The publication outlines common billing considerations and offers benchmarks and policy context where available. It highlights the clinical implications for transfusion services and blood bank testing, and summarizes payer coverage themes and coding guidance relevant to laboratory billing teams and hospital finance departments. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 86977 describes a laboratory procedure in which a lab analyst incubates patient serum with an inhibitor to prepare the specimen for identification of antibodies to red blood cells. This process is used to modify or neutralize interfering substances in the serum so that clinically significant hemagglutinins can be identified accurately.
-
Service type: Laboratory immunohematology procedure
-
Typical site of service: Clinical laboratory or hospital laboratory setting
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A patient presenting for immunohematology testing is typically an inpatient or outpatient whose blood sample requires antibody identification following a positive antibody screen or suspected hemolytic transfusion reaction. For example, a hospitalized patient with anemia and a positive indirect antiglobulin test (IAT) after recent transfusion undergoes serologic workup. The clinical workflow: a phlebotomy specimen is sent to the transfusion medicine or immunohematology laboratory; a technologist performs initial antibody screen and, if indicated, incubates patient serum with an inhibitor reagent to neutralize common autoantibodies or plasma proteins, as described by 86977, to allow identification of underlying alloantibodies. Results are documented in the laboratory information system and communicated to the transfusion service and ordering clinician for transfusion planning or further testing. Typical sites of service include hospital clinical laboratories, blood banks, and reference immunohematology labs.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional component for laboratory interpretation when separated from the technical service. |
TC |